Comoros Technology Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Comoros Technology Digest.

Press releases published on October 25, 2026

an hour ago

Leads Biolabs' LBL-034 Shows 21.8-Month Median PFS in First-in-Human RRMM Data at ESMO 2026, Validating Its Proprietary TCE Platform

Indeterminate GlobeNewswire

3 hours ago

ArriVent Announces Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at ESMO Congress 2026

Indeterminate GlobeNewswire

4 hours ago

Amarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA®/VASCEPA® (icosapent ethyl) Capsules on Top of Standard of Care Treatment in Patients Undergoing Liver Resection for Colorectal Cancer …

Indeterminate GlobeNewswire

5 hours ago

Automating SEO and Link Building for AI Agents with Rapid Indexer's New MCP Server1

Indeterminate GlobeNewswire

5 hours ago

Unfair Links Launches a Link Building Service for Local Backlinks and Google Business Profile Matched Links

Indeterminate GlobeNewswire

5 hours ago

NovaBridge Biosciences Reports Mature Phase 1b Data at ESMO 2026 Positioning Givastomig for Registrational Development

Indeterminate GlobeNewswire

6 hours ago

Libtayo® (cemiplimab) Longer-Term Data Show Increasing and Clinically Meaningful Overall Survival Benefit with Adjuvant Treatment in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)

Indeterminate GlobeNewswire

8 hours ago

BioNTech und Bristol Myers Squibb präsentieren ermutigende Daten aus globaler Phase-2-Studie mit Pumitamig bei fortgeschrittenem nicht-kleinzelligem Lungenkrebs nach Progression der Erkrankung unter einer Immuntherapie und Chemotherapie

Indeterminate GlobeNewswire

8 hours ago

BioNTech and Bristol Myers Squibb Report Encouraging Global Phase 2 Data for Pumitamig in Advanced NSCLC After Progression on Immunotherapy Plus Chemotherapy

Indeterminate GlobeNewswire